Supplementary_material_pdf - FDA Reported Use of Patient Experience Data in 2018 Drug Approvals

Supplemental Material, Supplementary_material_pdf for FDA Reported Use of Patient Experience Data in 2018 Drug Approvals by Cameron M. Kieffer, Alexis Reisin Miller, Benjamin Chacko and Andrew S. Robertson in Therapeutic Innovation & Regulatory Science